Copyright Reports & Markets. All rights reserved.

Global Orally Disintegrating Tablet Excipient Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Orally Disintegrating Tablet Excipient Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Binders
      • 1.2.2 Glidents
      • 1.2.3 Diluents
      • 1.2.4 Disintegrants
      • 1.2.5 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Anti-Psychotics Drug
      • 1.3.2 Anti-Epileptics Drug
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 BASF
      • 2.1.1 Business Overview
      • 2.1.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Ashland
      • 2.2.1 Business Overview
      • 2.2.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Ashland Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 ABF Ingredients
      • 2.3.1 Business Overview
      • 2.3.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 JRS Pharma
      • 2.4.1 Business Overview
      • 2.4.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Merck KGaA
      • 2.5.1 Business Overview
      • 2.5.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Roquette
      • 2.6.1 Business Overview
      • 2.6.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Roquette Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Shin-Etsu
      • 2.7.1 Business Overview
      • 2.7.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Evonik
      • 2.8.1 Business Overview
      • 2.8.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Evonik Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 DFE Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Meggle Pharma
      • 2.10.1 Business Overview
      • 2.10.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Anhui Sunhere Pharmaceutical
      • 2.11.1 Business Overview
      • 2.11.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Fuji Chemical Industries
      • 2.12.1 Business Overview
      • 2.12.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Daicel Corporation
      • 2.13.1 Business Overview
      • 2.13.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 McePharma (Vivesa holding)
      • 2.14.1 Business Overview
      • 2.14.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Cargill Incorporated
      • 2.15.1 Business Overview
      • 2.15.2 Orally Disintegrating Tablet Excipient Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Orally Disintegrating Tablet Excipient Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Orally Disintegrating Tablet Excipient Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Orally Disintegrating Tablet Excipient Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Orally Disintegrating Tablet Excipient Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Orally Disintegrating Tablet Excipient Market Analysis by Regions

    • 4.1 Global Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Orally Disintegrating Tablet Excipient Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 4.3 Europe Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 4.5 South America Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)

    5 North America Orally Disintegrating Tablet Excipient by Country

    • 5.1 North America Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Country
      • 5.1.1 North America Orally Disintegrating Tablet Excipient Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Orally Disintegrating Tablet Excipient Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 5.3 Canada Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)

    6 Europe Orally Disintegrating Tablet Excipient by Country

    • 6.1 Europe Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Orally Disintegrating Tablet Excipient Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Orally Disintegrating Tablet Excipient Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 6.3 UK Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 6.4 France Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 6.5 Russia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 6.6 Italy Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Orally Disintegrating Tablet Excipient by Country

    • 7.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Orally Disintegrating Tablet Excipient Revenue and Market Share by Country (2014-2019)
    • 7.2 China Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 7.3 Japan Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 7.4 Korea Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 7.5 India Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)

    8 South America Orally Disintegrating Tablet Excipient by Country

    • 8.1 South America Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Country
      • 8.1.1 South America Orally Disintegrating Tablet Excipient Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Orally Disintegrating Tablet Excipient Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Orally Disintegrating Tablet Excipient by Countries

    • 9.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Orally Disintegrating Tablet Excipient Sales and Growth Rate (2014-2019)

    10 Global Orally Disintegrating Tablet Excipient Market Segment by Type

    • 10.1 Global Orally Disintegrating Tablet Excipient Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Orally Disintegrating Tablet Excipient Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Type (2014-2019)
    • 10.2 Binders Sales Growth and Price
      • 10.2.1 Global Binders Sales Growth (2014-2019)
      • 10.2.2 Global Binders Price (2014-2019)
    • 10.3 Glidents Sales Growth and Price
      • 10.3.1 Global Glidents Sales Growth (2014-2019)
      • 10.3.2 Global Glidents Price (2014-2019)
    • 10.4 Diluents Sales Growth and Price
      • 10.4.1 Global Diluents Sales Growth (2014-2019)
      • 10.4.2 Global Diluents Price (2014-2019)
    • 10.5 Disintegrants Sales Growth and Price
      • 10.5.1 Global Disintegrants Sales Growth (2014-2019)
      • 10.5.2 Global Disintegrants Price (2014-2019)
    • 10.6 Others Sales Growth and Price
      • 10.6.1 Global Others Sales Growth (2014-2019)
      • 10.6.2 Global Others Price (2014-2019)

    11 Global Orally Disintegrating Tablet Excipient Market Segment by Application

    • 11.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2014-2019)
    • 11.2 Anti-Psychotics Drug Sales Growth (2014-2019)
    • 11.3 Anti-Epileptics Drug Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Orally Disintegrating Tablet Excipient Market Forecast (2019-2024)

    • 12.1 Global Orally Disintegrating Tablet Excipient Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Orally Disintegrating Tablet Excipient Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Orally Disintegrating Tablet Excipient Market Forecast (2019-2024)
      • 12.2.2 Europe Orally Disintegrating Tablet Excipient Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Orally Disintegrating Tablet Excipient Market Forecast (2019-2024)
      • 12.2.4 South America Orally Disintegrating Tablet Excipient Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Orally Disintegrating Tablet Excipient Market Forecast (2019-2024)
    • 12.3 Orally Disintegrating Tablet Excipient Market Forecast by Type (2019-2024)
      • 12.3.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Orally Disintegrating Tablet Excipient Market Share Forecast by Type (2019-2024)
    • 12.4 Orally Disintegrating Tablet Excipient Market Forecast by Application (2019-2024)
      • 12.4.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Orally Disintegrating Tablet Excipient Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Description

      Scope of the Report:
      The worldwide market for Orally Disintegrating Tablet Excipient is expected to grow at a CAGR of roughly 3.4% over the next five years, will reach 17800 million US$ in 2024, from 15580 million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Orally Disintegrating Tablet Excipient in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      BASF
      Ashland
      ABF Ingredients
      JRS Pharma
      Merck KGaA
      Roquette
      Shin-Etsu
      Evonik
      DFE Pharma
      Meggle Pharma
      Anhui Sunhere Pharmaceutical
      Fuji Chemical Industries
      Daicel Corporation
      McePharma (Vivesa holding)
      Cargill Incorporated

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Binders
      Glidents
      Diluents
      Disintegrants
      Others

      Binders had the biggest market share of 37% in 2018.

      Market Segment by Applications, can be divided into
      Anti-Psychotics Drug
      Anti-Epileptics Drug
      Others

      Anti-Epileptics Drug is the greatest segment of Orally Disintegrating Tablet Excipient application, with a share of 37% in 2018.

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Orally Disintegrating Tablet Excipient product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet Excipient, with price, sales, revenue and global market share of Orally Disintegrating Tablet Excipient in 2017 and 2018.
      Chapter 3, the Orally Disintegrating Tablet Excipient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Orally Disintegrating Tablet Excipient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Orally Disintegrating Tablet Excipient market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Orally Disintegrating Tablet Excipient sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now